We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$201M
AUM Growth
+$13.3M
Cap. Flow
+$2.55M
Cap. Flow %
1.27%
Top 10 Hldgs %
19.35%
Holding
712
New
41
Increased
229
Reduced
120
Closed
19

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$329K
2
UNP icon
Union Pacific
UNP
+$202K
3
ABT icon
Abbott
ABT
+$194K
4
R icon
Ryder
R
+$164K
5
CVX icon
Chevron
CVX
+$158K

Sector Composition

Rank Sector Weight
1 Technology 25.43%
2 Real Estate 18.25%
3 Industrials 12.28%
4 Healthcare 8.95%
5 Consumer Discretionary 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIB icon
501
ProShares Ultra NASDAQ Biotechnology
BIB
$88M
$6.5K ﹤0.01%
125
-25
-17% -$1.38K
ETON icon
502
Eton Pharmaceutcials
ETON
$1.2B
$6.45K ﹤0.01%
1,848
VOE icon
503
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
$6.37K ﹤0.01%
+46
New +$6.13K
KNSA icon
504
Kiniksa Pharmaceuticals
KNSA
$6B
$6.29K ﹤0.01%
447
LCID icon
505
Lucid Motors
LCID
$2.59B
$6.2K ﹤0.01%
90
BTI icon
506
British American Tobacco
BTI
$123B
$6.08K ﹤0.01%
183
GDDY icon
507
GoDaddy
GDDY
$11.6B
$6.01K ﹤0.01%
80
NLY icon
508
Annaly Capital Management
NLY
$17.1B
$6K ﹤0.01%
300
TRV icon
509
Travelers Companies
TRV
$78.7B
$5.9K ﹤0.01%
34
VCSH icon
510
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$5.9K ﹤0.01%
78
-341
-81% -$25.9K
FSCO
511
FS Credit Opportunities Corp
FSCO
$1.01B
$5.78K ﹤0.01%
+1,218
New +$5.4K
REGN icon
512
Regeneron Pharmaceuticals
REGN
$82.7B
$5.75K ﹤0.01%
8
ITCI
513
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.63K ﹤0.01%
89
DOCS icon
514
Doximity
DOCS
$4.61B
$5.61K ﹤0.01%
165
IXC icon
515
iShares Global Energy ETF
IXC
$2.71B
$5.58K ﹤0.01%
150
TYG
516
Tortoise Energy Infrastructure Corp
TYG
$1.08B
$5.43K ﹤0.01%
187
KN icon
517
Knowles
KN
$3.31B
$5.42K ﹤0.01%
300
CPRX
518
DELISTED
Catalyst Pharmaceutical
CPRX
$5.25K ﹤0.01%
391
SDC
519
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$5.25K ﹤0.01%
9,907
-3,007
-23% -$1.23K
HBI
520
DELISTED
Hanesbrands
HBI
$5.24K ﹤0.01%
1,155
RBLX icon
521
Roblox
RBLX
$26.8B
$5.24K ﹤0.01%
130
DYN icon
522
Dyne Therapeutics
DYN
$4.95B
$5.22K ﹤0.01%
464
DXCM icon
523
DexCom
DXCM
$33.2B
$5.14K ﹤0.01%
40
REPL icon
524
Replimune Group
REPL
$1.17B
$5.11K ﹤0.01%
220
TSN icon
525
Tyson Foods
TSN
$20.2B
$5.1K ﹤0.01%
+100
New +$5.44K

Similar funds

Truvestments Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Truvestments Capital held 712 positions worth $201M, up 7.1% from $188M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital's Q2 2023 filing shows 41 new, 229 increased, 120 reduced and 19 closed positions. Its largest new stake was Ready Capital: 11,266 shares worth $127K. The largest sale was Triton International Limited, an estimated $3.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Real Estate and Industrials.

  • Truvestments Capital's largest Q2 2023 buy was Ready Capital: 11,266 shares worth $127K.
  • Truvestments Capital added most to Merck in Q2 2023, an estimated $329K increase.
  • Truvestments Capital's biggest Q2 2023 reduction was Triton International Limited, cutting an estimated $3.64M.
  • Truvestments Capital fully exited BorgWarner in Q2 2023, selling an estimated $300K.
  • Truvestments Capital's ten largest holdings make up 19% of its $201M portfolio in Q2 2023.
  • Truvestments Capital opened 41 new positions and closed 19 in Q2 2023.
  • Truvestments Capital's portfolio value rose 7.1% quarter-over-quarter to $201M.

Based on Truvestments Capital's 13F filing for Q2 2023, filed 10 Aug 2023.